Zhisong He

Zhisong He

Auto-generated profile, based on publicly available information

Zhisong He

Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2019 in Nature
Verified
Journal Article
Closed access
PDF file
SKSabina Kanton
Sabina Kanton
MBMichael James Boyle
Michael James Boyle
ZHZhisong He
Zhisong He
MSMalgorzata Santel
Malgorzata Santel
AWAnne Weigert
Anne Weigert
JCJ. Gray Camp
J. Gray Camp

5 October 2022 in Nature
Verified
Journal Article
Open access
PDF file
JFJonas Simon Fleck
Jonas Simon Fleck
SJSophie Martina Johanna Jansen
Sophie Martina Johanna Jansen
DWDamian Wollny
Damian Wollny
FZFides Zenk
Fides Zenk
MSMakiko Seimiya
Makiko Seimiya
BTBarbara Treutlein
Barbara Treutlein
Self-organizing neural organoids grown from pluripotent stem cells1–3combined with single-cell genomic technologies provide opportunities to examine gene regulatory networks underlying human brain development. Here we acquire single-cell transcriptome and accessible chromatin data over a dense time course in human organoids covering neuroepithelial formation, patterning, brain regionalization and neurogenesis, and identify temporally dynamic and brain-region-specific regulatory regions. We developed Pando—a flexible framework that incorporates multi-omic data and predictions of transcription-factor-binding sites to infer a global gene regulatory network describing organoid development. We use pooled genetic perturbation with single-cell transcriptome readout to assess transcription factor requirement for cell fate and state regulation in organoids. We find that certain factors regulate the abundance of cell fates, whereas other factors affect neuronal cell states after differentiation. We show that the transcription factor GLI3 is required for cortical fate establishment in humans, recapitulating previous research performed in mammalian model systems. We measure transcriptome and chromatin accessibility in normal or GLI3-perturbed cells and identify two distinct GLI3 regulomes that are central to telencephalic fate decisions: one regulating dorsoventral patterning with HES4/5 as direct GLI3 targets, and one controlling ganglionic eminence diversification later in development. Together, we provide a framework for how human model systems and single-cell technologies can be leveraged to reconstruct human developmental biology.

11 March 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZHZhisong He
Zhisong He
JZJian Zhang
Jian Zhang
XSXiao-He Shi
Xiao-He Shi
LHLe-Le Hu
Le-Le Hu
XKXiangYin Kong
XiangYin Kong
KCKuo-Chen Chou
Kuo-Chen Chou
Study of drug-target interaction networks is an important topic for drug development. It is both time-consuming and costly to determine compound-protein interactions or potential drug-target interactions by experiments alone. As a complement, the in silico prediction methods can provide us with very useful information in a timely manner. To realize this, drug compounds are encoded with functional groups and proteins encoded by biological features including biochemical and physicochemical properties. The optimal feature selection procedures are adopted by means of the mRMR (Maximum Relevance Minimum Redundancy) method. Instead of classifying the proteins as a whole family, target proteins are divided into four groups: enzymes, ion channels, G-protein- coupled receptors and nuclear receptors. Thus, four independent predictors are established using the Nearest Neighbor algorithm as their operation engine, with each to predict the interactions between drugs and one of the four protein groups. As a result, the overall success rates by the jackknife cross-validation tests achieved with the four predictors are 85.48%, 80.78%, 78.49%, and 85.66%, respectively. Our results indicate that the network prediction system thus established is quite promising and encouraging.

26 September 2016 in eLife
Verified
Journal Article
Open access
FMFelipe Mora-Bermúdez
Felipe Mora-Bermúdez
FBFarhath Badsha
Farhath Badsha
SKSabina Kanton
Sabina Kanton
JCJ Gray Camp
J Gray Camp
BVBenjamin Vernot
Benjamin Vernot
WHWieland B. Huttner
Wieland B. Huttner
Human neocortex expansion likely contributed to the remarkable cognitive abilities of humans. This expansion is thought to primarily reflect differences in proliferation versus differentiation of neural progenitors during cortical development. Here, we have searched for such differences by analysing cerebral organoids from human and chimpanzees using immunohistofluorescence, live imaging, and single-cell transcriptomics. We find that the cytoarchitecture, cell type composition, and neurogenic gene expression programs of humans and chimpanzees are remarkably similar. Notably, however, live imaging of apical progenitor mitosis uncovered a lengthening of prometaphase-metaphase in humans compared to chimpanzees that is specific to proliferating progenitors and not observed in non-neural cells. Consistent with this, the small set of genes more highly expressed in human apical progenitors points to increased proliferative capacity, and the proportion of neurogenic basal progenitors is lower in humans. These subtle differences in cortical progenitors between humans and chimpanzees may have consequences for human neocortex evolution.

30 December 2021 in Nature Methods
Verified
Journal Article
Open access
PDF file
ZHZhisong He
Zhisong He
AMAshley Maynard
Ashley Maynard
AJAkanksha Jain
Akanksha Jain
TGTobias Gerber
Tobias Gerber
RPRebecca Petri
Rebecca Petri
BTBarbara Treutlein
Barbara Treutlein
Induced pluripotent stem cell (iPSC)-derived organoids provide models to study human organ development. Single-cell transcriptomics enable highly resolved descriptions of cell states within these systems; however, approaches are needed to directly measure lineage relationships. Here we establish iTracer, a lineage recorder that combines reporter barcodes with inducible CRISPR–Cas9 scarring and is compatible with single-cell and spatial transcriptomics. We apply iTracer to explore clonality and lineage dynamics during cerebral organoid development and identify a time window of fate restriction as well as variation in neurogenic dynamics between progenitor neuron families. We also establish long-term four-dimensional light-sheet microscopy for spatial lineage recording in cerebral organoids and confirm regional clonality in the developing neuroepithelium. We incorporate gene perturbation (iTracer-perturb) and assess the effect of mosaic TSC2 mutations on cerebral organoid development. Our data shed light on how lineages and fates are established during cerebral organoid formation. More broadly, our techniques can be adapted in any iPSC-derived culture system to dissect lineage alterations during normal or perturbed development.

20 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
ZHZhisong He
Zhisong He
LDLeander Dony
Leander Dony
JFJonas Simon Fleck
Jonas Simon Fleck
ASArtur Szałata
Artur Szałata
KLKatelyn X. Li
Katelyn X. Li
BTBarbara Treutlein
Barbara Treutlein
Human neural organoids, generated from pluripotent stem cells in vitro, are useful tools to study human brain development, evolution and disease. However, it is unclear which parts of the human brain are covered by existing protocols, and it has been difficult to quantitatively assess organoid variation and fidelity. Here we integrate 36 single-cell transcriptomic datasets spanning 26 protocols into one integrated human neural organoid cell atlas totalling more than 1.7 million cells 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26 . Mapping to developing human brain references 27,28,29,30 shows primary cell types and states that have been generated in vitro, and estimates transcriptomic similarity between primary and organoid counterparts across protocols. We provide a programmatic interface to browse the atlas and query new datasets, and showcase the power of the atlas to annotate organoid cell types and evaluate new organoid protocols. Finally, we show that the atlas can be used as a diverse control cohort to annotate and compare organoid models of neural disease, identifying genes and pathways that may underlie pathological mechanisms with the neural models. The human neural organoid cell atlas will be useful to assess organoid fidelity, characterize perturbed and diseased states and facilitate protocol development.